News for Madrigal Pharmaceuticals, Inc. (MDGL)

Fred Craves, Ph.D. to retire from Madrigal's Board of Directors in July 2025 CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals

Discover Madrigal Pharmaceuticals' Q4 earnings insights, with revised estimates hinting at potential surprises.

Madrigal Pharmaceuticals Inc (MDGL) announced on February 21, 2025, that it will participate in the 45th Annual TD Cowen Health Care Conference on March 4, 2025

**media[546605]**

Exploring the Latest 13F Filing and Investment Strategies John Paulson (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2024, pr

On December 31, 2024, JANUS HENDERSON GROUP PLC (Trades, Portfolio) executed a strategic transaction involving Madrigal Pharmaceuticals Inc (MDGL). The firm red

On December 31, 2024, Avoro Capital Advisors LLC (Trades, Portfolio) executed a significant transaction involving Arrowhead Pharmaceuticals Inc. The firm added

Overview of Avoro Capital Advisors LLC (Trades, Portfolio)'s Recent Transaction On December 31, 2024, Avoro Capital Advisors LLC (Trades, Portfolio) made a sign

On December 31, 2024, Avoro Capital Advisors LLC (Trades, Portfolio) executed a notable transaction involving Monte Rosa Therapeutics Inc. The firm reduced its

Significant Transaction in Stoke Therapeutics Inc On December 31, 2024, RTW INVESTMENTS, LP (Trades, Portfolio) executed a notable transaction by acquiring an a

On December 31, 2024, RTW INVESTMENTS, LP (Trades, Portfolio) executed a significant transaction involving Akero Therapeutics Inc (AKRO). The firm added 940,388

Significant Stock Acquisition by RTW INVESTMENTS, LP (Trades, Portfolio) On December 31, 2024, RTW INVESTMENTS, LP (Trades, Portfolio) executed a notable stock

On December 31, 2024, RTW INVESTMENTS, LP (Trades, Portfolio) executed a significant reduction in its holdings of ACADIA Pharmaceuticals Inc (ACAD). The firm de

Significant Reduction in ESSA Pharma Inc Shares On December 31, 2024, RTW INVESTMENTS, LP (Trades, Portfolio) executed a notable transaction involving ESSA Phar

On December 31, 2024, RTW INVESTMENTS, LP (Trades, Portfolio) executed a notable transaction involving SAB Biotherapeutics Inc. The firm added 389,059 shares to

On December 31, 2024, RTW INVESTMENTS, LP (Trades, Portfolio) made a significant move by reducing its stake in Dyne Therapeutics Inc (DYN) by 1,600,000 shares.

On December 31, 2024, RTW INVESTMENTS, LP (Trades, Portfolio) executed a significant transaction involving Taysha Gene Therapies Inc (TSHA). The firm reduced it

On December 31, 2024, RTW INVESTMENTS, LP (Trades, Portfolio) executed a significant transaction involving Sage Therapeutics Inc. The firm reduced its holdings

Madrigal Pharmaceuticals Inc (MDGL), a biopharmaceutical company specializing in treatments for metabolic dysfunction-associated steatohepatitis (MASH), has ann